Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Proposednewclinicopathologicalsurrogate Definitionsofluminalaandluminalb (her2 Negative)intrinsicbreastcancersubtypes Patrickmaisonneuve 1*'

Proposednewclinicopathologicalsurrogate Definitionsofluminalaandluminalb (her2 Negative)intrinsicbreastcancersubtypes Patrickmaisonneuve 1* published presentations and documents on DocSlides.

RESEARCHARTICLEOpenAccess

RESEARCHARTICLEOpenAccess

  • alida-meadow
  • 100 Slides

Proposednewclinicopathologicalsurrogate definition...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

  • test
  • 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 32 Slides

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 0 Slides

Clinical Practice Guideline Update. American Soci...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

  • danika-pritchard
  • 0 Slides

ASCO-CAP Recommendations For HER2 Testing in Brea...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

  • marina-yarberry
  • 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

  • norah
  • 38 Slides

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

  • carny
  • 14 Slides

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

  • arya
  • 28 Slides

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

  • ximena
  • 32 Slides

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

  • Kingslayer
  • 19 Slides

A. University of Tennessee Medical Center – Knox...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

  • unita
  • 59 Slides

Percent with Patients. Number of Patients (Median)...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

  • liane-varnes
  • 0 Slides

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

  • alexa-scheidler
  • 0 Slides

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

  • katrgolden
  • 50 Slides

Contents PageIntended Use 4Summary and Explanation...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

  • alida-meadow
  • 59 Slides

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

William J.

William J.

  • tawny-fly
  • 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

  • luanne-stotts
  • 0 Slides

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

  • debby-jeon
  • 0 Slides

Monica Brown, MPH, PhD. . California Cancer Regi...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

  • coursion
  • 1 Slides

across the breast cancer therapy spectrum. Phase I...

Nanotek & Expo 2014

Nanotek & Expo 2014

  • DaintyLittlePrincess
  • 16 Slides

Biodegradable . nanobrushes. for drug delivery. ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

  • emery
  • 8 Slides

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Central Asian Journal of

Central Asian Journal of

  • cady
  • 10 Slides

15 Medical and Pharmaceutical Sciences Innovation ...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

  • elizabeth
  • 49 Slides

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

  • wang
  • 55 Slides

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

  • gelbero
  • 35 Slides

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

  • lily
  • 29 Slides

Senior Investigator, . Breast Cancer Research. Ten...

CA BREAST D r S ana

CA BREAST D r S ana

  • oconnor
  • 68 Slides

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

  • unita
  • 31 Slides

Dr. Vicente Marco. Department of Pathology. Hospit...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

  • caroline
  • 43 Slides

Lisa A. Carey MD, . ScM. University of North Carol...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

  • delcy
  • 117 Slides

Trastuzumab-emtansine. : A . very. . nice. . poi...

Metastatic triple-positive

Metastatic triple-positive

  • marcos147
  • 59 Slides

breast. . cancer. . needs. . different. . ther...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • lois-ondreau
  • 31 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • alida-meadow
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

  • iris
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subty...

Negative Knowledge By David J Teece Definition Negative knowledge is a

Negative Knowledge By David J Teece Definition Negative knowledge is a

  • okelly
  • 3 Slides

form of learning about actions and paths to avoid ...

Preventing the negative outcomes of negative energy balance:

Preventing the negative outcomes of negative energy balance:

  • wilson
  • 1 Slides

The relationship between fatty acid metabolism and...

Systemic Therapy of Breast Cancer

Systemic Therapy of Breast Cancer

  • abigail
  • 28 Slides

Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhut...

Negative double ne of the most commonly used treatments in modern bidding is the negative double

Negative double ne of the most commonly used treatments in modern bidding is the negative double

  • tatiana-dople
  • 1 Slides

The negative double is an extremely broad topic f...

Copyright © 2024 DocSlides. All Rights Reserved